Fund IV is roughly 29% larger than its predecessor, which raised nearly $620 million including the executive fund, and is Blue Sea’s first vehicle dedicated exclusively to healthcare. The firm invests in North American lower-middle-market companies, typically with $5 million to $30 million of EBITDA, across healthcare technology, outsourced services, products and multi-site services.
The close caps a busy year. Blue Sea completed four exits in 2026, SignatureMD, WillowWood, One Physics and Spectrum Vision Partners, representing about $1.5 billion of total enterprise value, including its first continuation vehicle for One Physics. It also added three platforms: Scout, CompletePet and Dynamic Access.
Managing Partner J.R. Davis said the raise reflects investor conviction in the decision to focus the fund entirely on healthcare, where he said the team has consistently produced results, with more than 80% of equity value created through growth.
For LPs, the outcome reinforces two trends in today’s private equity fundraising market: specialists with a clear sector edge continue to attract capital, and managers that can show realized exits are closing quickly. Blue Sea’s mix of exits and a continuation vehicle gave investors distributions at a time when DPI has become a gating item for re-ups.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.